Zobrazeno 81 - 90
of 435
pro vyhledávání: '"Victor L. Serebruany"'
Publikováno v:
American Journal of Therapeutics. 21:91-98
FX06 is a naturally occurring fibrin-derived peptide demonstrated to confer cytoprotection in the setting of primary percutaneous coronary intervention. Because the effect of FX06 on human platelet, coagulation, and fibrinolysis biomarkers (PCFB) is
Publikováno v:
Thrombosis and Haemostasis. 111:3-7
SummaryThe recently published, largest trial with cangrelor, the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION)-PHOENIX, suggested that the experimental agent significantly reduced the rate of stent
Publikováno v:
Thrombosis and Haemostasis. 112:4-9
SummaryTwo oral antiplatelet agents have been recently introduced for acute coronary syndromes indication providing alternatives for dual therapy with aspirin and clopidogrel. In fact, worldwide prasugrel has been on the market for four years, and ti
Autor:
Hector A. Cabrera-Fuentes, Victor L. Serebruany, Sung-Cheol Yoon, Kyung Il Park, Young Rak Cho, Kwang-Min Lee, Tae Ho Park, Moo Hyun Kim, Young Dae Kim
Publikováno v:
Thrombosis and haemostasis. 117(5)
SummaryThe optimal duration and cancer risks of antiplatelet therapy following percutaneous coronary intervention (PCI) are unclear. We compared cancer and all-cause mortality after dual antiplatelet therapy (DAPT) for the combination of clopidogrel
Autor:
Mee Sook Roh, Jong Sung Park, Chong-Rak Kim, Sun Young Choi, Moo Hyun Kim, Victor L. Serebruany
Publikováno v:
Lipids. 52(5)
Adiponectin is a polypeptide known to inhibit cardiac fibrosis via the activation of adenosine monophosphate-activated protein kinase (AMPK). Statins can also activate AMPK, resulting in the secretion of adiponectin. We determined whether atorvast
Publikováno v:
Journal of Neurotrauma. 30:1881-1887
Severe blast exposures are frequently complicated with fatal intracranial hemorrhages. However, many more sustain low level blasts without tissue damage detectable by brain imaging. To investigate effects of nonlethal blast on thrombin-related biomar
Publikováno v:
Polish Archives of Internal Medicine. 127:720-721
Autor:
Seth D. Fortmann, Victor L. Serebruany
Publikováno v:
Expert Review of Cardiovascular Therapy. 13:867-869
The International Central Adjudication Committee (ICAC) is responsible for blinded independent assessment of complex clinical events in randomized trials. In this study, we analyze the constituence and impact of the ICAC in the PLATO trial. The PLATO
Autor:
Elvira Fattakhova, Vladimir Demchinsky, Tatiana Baklanova, Victor L. Serebruany, Dmitry Zateyshchikov
Publikováno v:
Cardiology. 132:65-67
Background: Coronary stent infections in general and stent abscesses (SAs) in particular are rare but often deadly complications. Most SAs manifest with fever and chest pain within 30 days after intervention and require antibiotics and stent removal.
Autor:
Marian Zembala, Jonas Hallén, Dan Atar, Victor L. Serebruany, Andrzej Mysiak, Wiktor Kuliczkowski, Joanna Urbaniak, Lech Poloński, Mieczysław Woźniak
Publikováno v:
Kardiologia Polska. 71:453-463
Background: Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) play a role in heart remodelling after acutemyocardial infarction (MI). Their activity is connected with outcome and heart failure development. There is little data on M